Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Bionano Genomics' Stock Spikes on Study Showing Strength of Structural Variation Detection Tech

Bionano Genomics' Stock Spikes on Study Showing Strength of Structural Variation Detection Tech

Dec 23, 2020
|
staff reporter

NEW YORK – Shares of Bionano Genomics were up more than 40 percent in Wednesday afternoon trading after the company highlighted the results of a recently published preprint study demonstrating the superiority of its optical mapping technology for detecting large structural variations (SVs) in de novo sequencing data.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

COVAX's First Shipment

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.

Support for Another

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.

New Prototype Test

Researchers in France are developing a new, fast test for SARS-CoV-2 that initial testing indicates may be highly accurate, the Guardian says.

Cell Studies on SARS-CoV-2 Spike Variant, Host Transcriptomes, Glioma-Infiltrating T Cells

In Cell this week: analysis of fitness patterns among SARS-CoV-2 isolates, single-cell transcriptome analysis of immune features in COVID-19, and more.

What's Popular?

In Business News

  1. WuXi Diagnostics Closes $150M Series B Financing Round

  2. NeoGenomics Q4 Revenue Grows 18 Percent, CEO to Retire

  3. Myriad Genetics Quarterly Revenues Decline 21 Percent

  4. BioMérieux Reports 21 Percent Revenue Growth in Q4

  5. Qiagen, Inovio Expand CDx Partnership, Starting With NGS Test for Cervical Dysplasia Therapy

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.